INTRODUCTION: Atypical teratoid/rhabdoid tumors (ATT/RT) of the central nervous system (CNS) are uncommon malignancies of childhood with an aggressive course and a uniformly fatal outcome. METHODS: The medical records, radiographic images and pathologic files at the Rainbow Babies and Childrens Hospital over the previous 6 years were retrospectively reviewed. RESULTS: Eight children underwent surgery for CNS ATT/RT at our institution since 1996. There were 6 boys and 2 girls. Median age at presentation was 21 months. Four tumors had multifocal disease at the time of diagnosis. Six patients received multiagent chemotherapy including 3 patients with autologous bone marrow transplantation, and 6 patients received radiation therapy. Median survival was 9 months from the time of diagnosis. CONCLUSIONS: In spite of aggressive therapy, the prognosis for ATT/RT remains dismal. The search for effective treatment strategies will require a better understanding of the biology and molecular genetics of this tumor. Copyright 2002 S. Karger AG, Basel
INTRODUCTION: Atypical teratoid/rhabdoid tumors (ATT/RT) of the central nervous system (CNS) are uncommon malignancies of childhood with an aggressive course and a uniformly fatal outcome. METHODS: The medical records, radiographic images and pathologic files at the Rainbow Babies and Childrens Hospital over the previous 6 years were retrospectively reviewed. RESULTS: Eight children underwent surgery for CNS ATT/RT at our institution since 1996. There were 6 boys and 2 girls. Median age at presentation was 21 months. Four tumors had multifocal disease at the time of diagnosis. Six patients received multiagent chemotherapy including 3 patients with autologous bone marrow transplantation, and 6 patients received radiation therapy. Median survival was 9 months from the time of diagnosis. CONCLUSIONS: In spite of aggressive therapy, the prognosis for ATT/RT remains dismal. The search for effective treatment strategies will require a better understanding of the biology and molecular genetics of this tumor. Copyright 2002 S. Karger AG, Basel
Authors: S P Meyers; Z P Khademian; J A Biegel; S H Chuang; D N Korones; R A Zimmerman Journal: AJNR Am J Neuroradiol Date: 2006-05 Impact factor: 3.825
Authors: Sujatha Venkataraman; Irina Alimova; Tiffany Tello; Peter S Harris; Jeffrey A Knipstein; Andrew M Donson; Nicholas K Foreman; Arthur K Liu; Rajeev Vibhakar Journal: J Neurooncol Date: 2012-01-15 Impact factor: 4.130
Authors: Kong Jung Au Yong; Jacob L Jaremko; Lennart Jans; Ravi Bhargava; Lee T Coleman; Vivek Mehta; Michael R Ditchfield Journal: Pediatr Radiol Date: 2012-11-10
Authors: Jeffrey A Knipstein; Diane K Birks; Andrew M Donson; Irina Alimova; Nicholas K Foreman; Rajeev Vibhakar Journal: Neuro Oncol Date: 2011-12-08 Impact factor: 12.300
Authors: V Samaras; A Stamatelli; E Samaras; I Stergiou; P Konstantopoulou; V Varsos; A R Judkins; J A Biegel; C Barbatis Journal: Clin Neuropathol Date: 2009 Jan-Feb Impact factor: 1.368